If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.50
Bid: 40.00
Ask: 41.00
Change: -1.30 (-3.11%)
Spread: 1.00 (2.50%)
Open: 40.50
High: 40.50
Low: 40.50
Prev. Close: 41.80
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Benecol Supplement Capsule Sale Malta

9 Dec 2014 07:00

RNS Number : 1662Z
Venture Life Group PLC
09 December 2014
 



 

 

Venture Life Group plc

("Venture Life" or "the Group")

First sale of new Benecol® cholesterol-lowering capsules in Malta

 

Bracknell, UK - 9 December 2014: Venture Life Group plc (AIM: VLG), the international consumer products group addressing the self-care needs of the ageing population, announces the first sale of its new Benecol® food supplement capsules. This follows the signing of a distribution agreement earlier this year between Venture Life and Alf Mizzi & Sons (Marketing) Group ("Alf Mizzi") under which Venture Life granted Alf Mizzi exclusive distribution rights to Benecol in capsule form in Malta. Benecol is a registered trademark of Raisio plc and is licensed to Alf Mizzi in Malta.

 

The new Benecol food supplement in capsule form is being sold through pharmacies in Malta with particular promotion to doctors, healthcare specialists and pharmacists. Benecol products are proven to reduce low density lipo-protein (LDL) cholesterol, and in capsule form the product offers the consumer portability, convenience and a long shelf life.

 

Malta is the first market to launch the new Benecol food supplement in capsule form using Raisio's patented plant stanol ingredient and under the Benecol brand.

 

Alf Mizzi is the largest FMCG distributor in Malta and has been selling Benecol as a functional food (in yogurt drink and spread form) for over seven years. It has built a market leading position in Malta with Benecol yogurt drinks.

 

Jerry Randall, Chief Executive Officer of Venture Life, commented:

"This is a very significant landmark for Venture Life. Malta is the first territory where the new food supplement, in capsule form, is available alongside a functional food version of Benecol that is already well-established in the local market.

 

"We share Alf Mizzi's confidence that the distribution of the Benecol capsule will increase the overall market for the brand in Malta, and we look forward to working with Alf Mizzi as they build their Benecol business further in this new distribution channel."

 

 

- Ends -

 

  

 

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer

James Hunter, Chief Financial Officer +44 (0) 1344 742870

 

Panmure Gordon (UK) Limited Freddy Crossley / Duncan Monteith +44 (0) 20 7886 2500Corporate Finance

Tom SalvesenCorporate Broking

 

Square1 Consulting

David Bick

Mark Longson +44 (0) 20 7929 5599

 

 

Notes to editors

 

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercializing products for the ageing population. The Group's product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

 

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical device and cosmetic sectors.

The Group's own branded products are currently sold or partnered in over 40 countries and currently include:

· food supplements to maintain brain function and memory;

· dermo-cosmetics for addressing the signs of skin ageing and hair loss, and

· medical devices for improving conditions such as minor aches and pains, dry eyes and itchy skin.

 

The Company has a healthy development pipeline including products in areas such as diabetes, cardiovascular health, obesity, cognitive function and skin ageing. Products coming from the pipeline will be expected to have intellectual property protection and be supported by independent clinical evidence of efficacy.

About Raisio plc and Benecol®

Raisio plc is a Finnish company, whose shares are listed on NASDAQ OMX Helsinki Ltd. Benecol is Raisio's top innovation. It is an original expert in cholesterol lowering functional foods. The brand was launched in Finland in 1995 and is now sold in some 30 countries worldwide. Benecol, originally introduced as a spread, has expanded into various food forms; yogurts, yogurt drinks, breads and cream cheese spreads.

 

Benecol products contain the unique and patented ingredient - Plant stanol ester. This ingredient is safe, natural and supported by more than 70 published clinical studies that demonstrate significant efficacy of the cholesterol lowering properties of the product.

 

Venture Life has developed a capsule form of Benecol that contains the recommended daily dosage levels of Plant stanol ester. Benecol trademark is licensed to Venture Life by Raisio in certain countries.

 

About Alf Mizzi

Alf Mizzi was founded in 1915 as a food and clothing importer and distributor. The family run business has grown, diversified and established itself as a leading company in Malta, with over 900 employees.

 

Within the FMCG sector, Alf Mizzi is the market leader in Malta, marketing and distributing globally recognised chilled, frozen and grocery food brands. Alf Mizzi invests extensively in marketing across multiple channels; TV, online and outdoor advertising, and distributes to small local stores as well as supermarkets.

 

Alf Mizzi has been distributing Benecol products in functional food form in supermarkets and other food stores since 2007. With the launch of Benecol capsules, Alf Mizzi is extending its distribution into the pharmacy channel, which will complement its existing Benecol product distribution.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQVLFBZLFBFBK
Date   Source Headline
19th Apr 20247:00 amRNSRCF in Place and New Partner in the USA
9th Apr 20247:00 amRNSFinal Results for year ended 31 December 2023
4th Apr 20247:00 amRNSNotice of Results and Investor Presentation
19th Feb 20245:18 pmRNSHolding(s) in Company
6th Feb 202410:48 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update
20th Dec 20232:00 pmRNSHolding(s) in Company
28th Nov 202312:28 pmRNSHolding(s) in Company
22nd Nov 20234:05 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
31st Oct 20233:11 pmRNSHolding(s) in Company
17th Oct 20231:54 pmRNSHolding(s) in Company
25th Sep 20237:01 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Statement
5th Jul 20237:00 amRNSPDMR Shareholdings – Grant of Awards
26th Jun 20234:48 pmRNSDirector/PDMR Shareholding
25th May 20231:54 pmRNSDirector Dealings
22nd May 20233:01 pmRNSResults of AGM
22nd May 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSBoard Change
9th May 20237:00 amRNSNotice of Capital Markets Event
28th Apr 202310:05 amRNSAnnual Report and Notice of AGM
5th Apr 20231:53 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSFinal Results for year ended 31 December 2022
31st Mar 20237:00 amRNSInvestor Presentation
13th Mar 20237:00 amRNSUpdate re Revolving Credit Facility
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSTrading Statement
9th Jan 20237:00 amRNSLicensing and distribution agreements
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:37 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSAcquisition and trading update
10th Oct 20227:00 amRNSDirectorate Changes
23rd Sep 202211:08 amRNSInvestor Presentation
22nd Sep 20227:00 amRNSHalf-year Report
25th Jul 202212:00 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSTrading Update
20th Jun 20222:31 pmRNSResults of AGM
10th Jun 202212:21 pmRNSDirector/PDMR Shareholding
9th Jun 20225:53 pmRNSAnnual Report & Notice of AGM - Correction
7th Jun 20227:00 amRNSAnnual Report & Notice of AGM
30th May 20224:22 pmRNSDirector/PDMR Shareholding
30th May 20227:00 amRNSDirectorate Changes
23rd May 20224:27 pmRNSHolding(s) in Company
20th May 20227:00 amRNSInvestor Presentation
17th May 20227:00 amRNSDirectorate Changes
17th May 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.